BACKGROUND AND SIGNIFICANCE
Cytokines and immune cells play a central role in both health and disease. [1] [2] [3] [4] Cytokines are small proteins that are secreted from a variety of immune cell types, are involved in many biological processes, and act as key regulators of the immune system. 5 The availability of different types of immune-related data is increasing dramatically, providing an attractive source of data for systematic analysis, which could help identify useful immune-related relationships and areas for future research. However, utilizing these data efficiently increasingly requires the integration of different data sources. Researchers must be able to integrate their data with other existing resources and compare the results to prior knowledge. For example, by integrating large numbers of microarray studies, it is possible to compare the results from different studies 6 and carry out meta-analyses. Furthermore, different kinds of experimental data (eg, genomics, transcriptomics, and proteomics) can be integrated to gain a better view of an investigated system or disease and to help identify patterns that would otherwise be missed.
One rich, readily available source of disease-related knowledge is the corpus of published scientific research. Many disease-related phenotypic trends are captured in biomedical literature and can be extracted from freely available PubMed 7 records. Numerous text mining tools and techniques have been specifically developed for mining and extracting information from PubMed abstracts and full articles. 8, 9 One such tool is SemRep, 10 which specializes in extracting semantic relations from biomedical free text in MEDLINE citations. However, many of these tools and approaches are complex, multi-stage, and task-or domain-specific. Other established tools include MedLEE (Medical Language Extraction and Encoding), 11, 12 a system based on natural language techniques that has been repeatedly demonstrated to be applicable to many clinical fields, from chest radiographs to pathology reports. 11, 13, 14 However, MedLEE specializes in information extraction from clinical textual records rather than other biomedical text sources, such as PubMed abstracts.
In contrast, an easily accessible source of information is the cooccurrences of entities or concepts in Medical Subject Headings (MeSH) terms associated with PubMed records. MeSH is the National Library of Medicine's controlled vocabulary thesaurus; it consists of sets of terms naming descriptors in a hierarchical structure and is used for indexing MEDLINE PubMed publications. MeSH descriptors associated with each MEDLINE citation are manually assigned and provide a straightforward, yet potentially very useful, knowledge resource. Numerous works using concept co-occurrences in biomedical texts or in associated MeSH terms have been previously described. [15] [16] [17] [18] [19] [20] [21] [22] Examples of the usefulness of this data source range from using MeSH descriptor co-occurrence frequencies for the automated annotation of articles 19 to constructing and analyzing a network of cooccurring terms. 18 Disease-related information can also be gathered from a wide range of experimental data repositories. For example, large-scale expression studies are made freely available by the Gene Expression Omnibus, which currently contains nearly 1.5 million microarrays from almost 60 000 studies. 23 Data from such sources can be synthesized, integrated, and compared, to facilitate the investigation of the system or diseases in focus.
To date, integrated immune-related data, such as text-extracted concepts and cytokine level measurements, have not, to our knowledge, been systematically and methodically examined in the context of disease. One database, ImmuneXpresso, 24 focuses on the relationships between immune cells and cytokines extracted from the literature. In addition, cell-specific gene expression data was used to cross-validate cytokine-mediated cell-cell interactions and suggest novel interactions. However, data forms other than text-derived data (such as experimental data and clinical data) are not incorporated into ImmuneXpresso, a limitation that is addressed in the work presented here. We present herein a novel integration and analysis of MeSH descriptor-derived cytokine-disease associations and cytokine-specific gene expression data. By integrating these data, we were able to examine relationships between cytokines and diseases that would otherwise be missed. We provide several compelling use cases and examples of the utility of this approach and the knowledge gained by using it.
OBJECTIVES
This work aims to examine immune-related patterns in the context of diseases by suggesting links between different diseases and pinpointing unaddressed areas of research. By intelligently integrating knowledge from different sources, specifically information from the biomedical literature and cytokine gene expression data, we are able to identify and investigate patterns and associations that would otherwise be missed.
MATERIALS AND METHODS
Extracting PubMed Records-Associated MeSH Descriptors A list of disease names and name synonyms was extracted from the Human Disease Ontology 25 (downloaded from the Open Biomedical Ontologies Foundry 26 in February 2014) and used for capturing PubMed record-associated MeSH disease terms. 27 The Human Disease Ontology was selected for this project, for its comprehensive coverage of human disease concepts and its ontological properties, which could also be used to conduct complex queries. A list of cytokine MeSH descriptors (such as "interferon gamma," "transforming growth factor beta," and "chemokine CCL3") was manually compiled by a domain expert, who browsed MeSH's sub-trees and selected those descriptors that were deemed relevant to this work. Similarly, a list of immune-related cell type MeSH descriptors (such as "lymphocytes," "Th1 cells," and "basophils") was also compiled (see Supplementary File 1). The MeSH Supplementary Concept Records, which include concepts that are supplementary to MeSH descriptors, were not used to capture cytokine concepts, because the majority of these concepts represent species-specific variations and the PubMed records used for this work were limited to those linked to the keyword "human" (see below).
For proof of concept, PubMed records (n ¼ 2 405 255) were exported (in February 2014) from the National Center for Biotechnology Information in the MEDLINE format, using the key word "human" in a text-word search of PubMed. Using a script implemented in Perl, the list of associated MeSH descriptors was recorded for each PubMed record. The lists of cytokine names, cell types, and diseases (compiled as described above) were searched for exact matches with the MeSH descriptors associated with each record ( Figure 1A ). Therapeutics-and diagnostics-related MeSH descriptors (from a list compiled by a domain expert, which included terms such as "diagnosis," "prognosis," and "therapy"; see Supplementary File 1) were also identified. These MeSH descriptors were used to assign each record to one of the two categories (therapeutics or diagnostics), both categories, or neither category.
Evaluation of MeSH Descriptor Co-occurrences
To evaluate whether co-occurrences of MeSH descriptors (computed as described below) within the same PubMed record represent a true (meaningful and feasible) relationship between the terms, 100 random abstracts were selected from our dataset and evaluated by a domain expert with a significant background in immunology. For each abstract, each pair of MeSH descriptors (disease-cell, disease-cytokine, or cell-cytokine) was evaluated to determine whether it represented a true relationship, an indirect relationship, or an incorrect relationship. The complete evaluation results are available as Supplementary File 2. A true relationship is one that is clearly and explicitly stated in the text. For example, the association between non-small cell lung carcinoma and dendritic cells would be considered a true relationship, based on the text "we investigated the changes in DC phenotype and expression of B7-H molecules induced by non-small cell lung cancer." 28 Indirect relationships are ones that can be understood or inferred from the text but are not explicit. For example, the association between "CD4 positive T-lymphocytes" and "breast neoplasms" would be considered indirect, because, in the text "we review here evidence for the importance of specific CD4
þ Th activation in cancer immunotherapy" 29 breast neoplasms are not explicitly mentioned (nor are they explicitly mentioned anywhere else in the abstract), although cancer, in general, is. An incorrect relationship between two concepts is one in which, for example, one of the concepts is not mentioned at all in the text or, based on the text, there is no demonstrated relationship between the two concepts (directly or indirectly).
Clustering Analysis of MeSH Descriptor Co-occurrence Data
In order to examine disease similarities based on cytokine cooccurrences in the literature, we set out to cluster these patterns of co-occurrences. To do so, a quantitative cytokine-disease matrix was generated by obtaining, for each disease and cytokine in the database, a count of the number of records mapped to that disease and that cytokine. Similar matrices for cytokine-cells and cells-disease cooccurrences were also generated (see Supplementary File 3).
Using these matrices as input, hierarchical clustering was performed using (1-correlation) as the distance measure, taking into consideration only co-occurrences that were supported by 10 or more records ( Figure 1A ). To identify statistically significant clusters, the pvclust package in R 30 was used, with the following parameters: method -"average," alpha variable -0.95 (P < .05), and the number of bootstrapping -1000. The complete clustering results are provided as Supplementary File 4.
Gene Expression Analysis
Processed gene expression data for a variety of disease phenotypes were obtained from the Gene Expression Omnibus, 23 with selection limited to only those studies that used the Affymetrix Human Genome U133, U133A, or U133 Plus 2.0 arrays ( Figure 1B ). Only studies that examined a disease state in comparison to a healthy (or equivalent) control were selected (resulting in a total of 22 datasets, representing 28 disease phenotypes, as described in a previous article 31 ). These studies are listed in Supplementary File 5. The diseases included in this dataset are: Huntington's disease, melanoma, polycystic ovary syndrome, bipolar disorder, vulvar intraepithelial neoplasia, acne, psoriasis, Parkinson's disease, teratozoospermia, endometriosis, adenoma, Down's syndrome, multiple sclerosis, heart failure, squamous cell cervical cancer, sickle cell anemia, obesity, renal clear cell carcinoma, and type 1 and type 2 diabetes.
To identify diseases with similar cytokine expression patterns, fold changes between the disease and the control states were calculated for probes representing cytokine genes, which were manually selected (n ¼ 51). A median of the fold changes was calculated for cytokine genes represented by more than one probe. Fold changes were then used to calculate Pearson correlations between diseases (Supplementary File 6). Because we used a within-study measure (i.e. the fold change between disease and control states), to compare patterns between different studies, it was not necessary to conduct uniform processing, such as normalization, for the datasets that were examined.
Comparing MeSH Descriptor-Derived Co-occurrences and Cytokine Gene Expression
To examine similarities and differences between MeSH descriptorderived co-occurrences and cytokine gene expression, data for matching diseases and cytokines from both datasets were collected. For each of the diseases for which data in our expression dataset was available, the matching MeSH descriptor-derived cytokine-disease cooccurrence counts were collected into a matrix and transformed into z-scores. Cytokine gene expression fold changes were also collected into a matrix and transformed into z-scores. The transformation of values from both datasets to z-scores, a method for data normalization regularly used in expression microarray analysis, was necessary, in order to standardize the fold changes and co-occurrence counts (which represent very different types of values) and make them comparable. Twenty-six disease phenotypes were matched in the MeSH descriptor dataset (excluding vulvar intraepithelial neoplasia and teratozoospermia, which were unmatched). A differential matrix of 26 matching disease phenotypes over 51 matching cytokines was generated by subtracting the cytokine gene expression fold changes z-score (absolute values) matrix from the MeSH descriptor co-occurrences zscore matrix ( Figure 1C ). The resulting differential matrix was plotted using the color2D.matplot function in the plotrix R package.
The dataset is freely available in MySQL, 30 as Supplementary File 7.
RESULTS
Extracting Cytokine, Cell Type, and Disease Co-occurrences from Biomedical Literature MeSH descriptors associated with over 2.4 million PubMed records were studied for occurrences of cytokines, disease, and cell type terms (Figure 2) , and the co-occurrences of these different types of entities within the biomedical literature were captured. This dataset includes 265 968 co-occurrences between 85 different cytokines, 1041 diseases, and 64 cell types. MeSH descriptors were also used to categorize records into those associated with therapeutics or diagnostics (see Materials and Methods section). We next set out to evaluate the nature and capability of MeSH descriptor co-occurrences to capture true relationships and dependencies between concepts, as they are described in the biomedical literature. From 100 randomly selected records, 253 pairs of MeSH descriptors of different types (cytokine, disease, or cell type) were captured by our computational analysis. Of these co-occurrences, 61.7% were found to represent real relationships or dependencies in the abstracts associated with the records, and an additional 10.7% were found to represent indirect relationships between the terms. The remaining co-occurrences (27.7%) were found to represent incorrect relationships. These findings are a strong indication that the co-occurrence of MeSH descriptors linked to any given PubMed record are a good source for mining dependencies between different types of biomedical entities.
Discovering Biomedical Relationships Through MeSH Descriptor
Co-occurrences Using the MeSH descriptor co-occurrence counts, 8693 diseases were clustered based on their co-occurrence with cytokines, generating 45 significant clusters (P < .05).
The resulting disease clusters reflect, at least in some cases, current medical knowledge. In the example provided in Figure 3A , many blood-related diseases (such as anemia, uremia, hypertension, polycythemia vera hemochromatosis, thrombocytopenia, and iron overload) are grouped together and characterized by a high association with erythropoietin, a hormone that controls red blood cell production. In another example ( Figure 3B ), allergy-related diseases (food allergy, asthma, and hypersensitivity reaction type I disease) were grouped together based on a strong association between these diseases and a variety of different cytokines, such as interleukin 4 (IL-4), IL-5, IL-13, and interferon gamma (IFNc). These conditions all involve some immune response to allergens, and the cytokines associated with this cluster have all been shown to be major contributors to conditions such as asthma and allergies. 31 Clustering of cell types, using MeSH descriptor co-occurrence counts, also captures common medical knowledge. In the example illustrated in Figure 3D , different forms of red blood cells were clustered together. Taken together, these clusters of diseases or cell types based on their association with cytokines, as captured by MeSH descriptor associations in the literature, represent current medical views, thus validating our dataset.
Other clusters can be used to generate interesting hypotheses regarding links between diseases, based on their association patterns with cytokines. In one example, Figure 3C shows a cluster of diseases characterized by their high association with IFNc and tumor necrosis factor alpha (TNFa). This cluster contains an unusual grouping of several different types of diseases: different parasitic infections (such as leishmaniasis, leprosy, and toxoplasmosis), different types of cancer (such as retinoblastoma and neuroblastoma) and other diseases (such as celiac disease and Graves' disease). Clusters of this kind could be used to generate hypotheses regarding the link between these different types of diseases and a possible shared immunological mechanism. In this case, it could be hypothesized that, although these diseases do not share an obvious common mechanism, because they are all highly associated with IFNc and TNFa in our MeSH descriptor co-occurrence data, they may share some common immunological basis. One possible theory is that the commonality between these diseases is the formation of granulomas, a form of localized nodular inflammation found in tissues and comprising mostly mononuclear cells. 34 Tuberculosis, aspergillosis, leishmaniasis, infectious mononucleosis, and toxoplasmosis are all granulomatous infections. On the other hand, although Graves' disease, celiac disease, retinoblastoma, and neuroblastoma are not granulomatous by definition, there have reportedly been cases of each of the diseases in which granulomas were observed. [35] [36] [37] [38] Although this could be a possible explanation for the grouping of these diseases seen in our analysis, this theory is only one of many possibilities and must be further investigated and validated before any conclusions can be drawn.
Cytokine Gene Expression
In order to further validate the MeSH descriptor-derived cooccurrences dataset, a correlation analysis was performed on cytokine gene expression levels in a variety of disease phenotypes (Figure 4) .
Several disease pairs were found to be highly correlated based on cytokine gene expression. In one example, type 1 and type 2 diabetes were highly correlated (r ¼ 0.85). Both types of diabetes share several similar etiology aspects, including immune system involvement. Death of pancreatic b-cells occurs in both types of diabetes, and, in both diseases, it seems that inflammatory processes and cytokines are involved. 37 We observed that, in peripheral blood mononuclear cells samples collected from children with type 1 or type 2 diabetes, there was a significant over-expression of chemokine (C-C motif) ligand 2 (CCL2) in the disease states compared with the control samples (fold changes of 4.3 and 4.6, respectively). Additionally, chemokine (C-X-C motif) ligand 1 (CXCL1), IL-1b, and IL-8 were significantly overexpressed in both diseases and IL-18, IL-5, and platelet factor 4 (PF4) were significantly under-expressed in both forms of diabetes. Thus, our results further demonstrate the immunological link between the two diseases.
A second pair of diseases correlated on cytokine expression are cervical cancer and psoriasis (r ¼ 0.96). In addition to a similar pattern of cytokine expression, the single nucleotide polymorphism (SNP) rs6887695, located in the IL-12b gene, was found to be associated with an increased risk for both cervical cancer and psoriasis, 40, 41 indicating that there is a genetic commonality between these two diseases in addition to the transcriptional similarities. Patterns of co-occurrence of cervical cancer and psoriasis with cytokines in biomedical texts were also found to correlate with one another (r ¼ 0.75, P < .05), thus validating that disease similarities found by gene expression and genetic markers can also be captured by MeSH descriptor co-occurrences.
Identifying Potentially Interesting Cytokine-Disease Associations
To examine cytokine-disease associations that are of potential interest but have not been examined in the past, cytokine gene expression fold changes in various diseases were compared to cytokine co-occurrence counts from the biomedical literature ( Figure 5) . A differential 
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of disease phenotypes matched in both datasets was created by calculating the difference between cytokine expression fold change z-scores (absolute value) and MeSH descriptor co-occurrences zscores. If a given cytokine is highly up-or down-regulated in a given disease and there is also a high cytokine co-occurrence count with that disease based on the data mined from the biomedical literature, the difference between the cytokine expression fold change and the MeSH descriptor co-occurrence z-scores will be around zero, indicating that although such cytokines are interesting in the context of that disease, these associations have already been extensively investigated. In contrast, if a cytokine gene is highly up-or down-regulated in a given disease but has a low MeSH descriptor co-occurrence with that disease, the difference between the cytokine expression fold change and the MeSH descriptor co-occurrence z-scores will be a negative value. A very negative value (represented in red in Figure 5 ) indicates that that disease-cytokine association is potentially interesting but has not been extensively reported on in the biomedical literature.
In one example, interferon alpha 8 (IFNa 8) is highly up-regulated in severe and moderate Alzheimer's disease (over four times higher gene expression levels than in control samples), yet the association between IFNa 8 and Alzheimer's disease has not been extensively investigated in the biomedical literature. On the other hand, although the expression of TNFa is down-regulated in obesity, the association between the two has been extensively reported on in the biomedical literature and thus is less potentially interesting for future investigations.
DISCUSSION
In this work, we examined the usefulness of exploring and integrating literature-derived data with gene expression data for discovery and hypothesis generation regarding potential links between diseases and immunity. As demonstrated in other fields of research, integrating several sources of information provides a holistic view of the domain that would otherwise not have been achieved.
Integrating Literature-Based and Molecular Data for Research and Discovery
The potential usefulness of MeSH descriptor co-occurrences is demonstrated in several examples. By clustering these co-occurrences, we showed that, although some clusters reflected current medical views (thus validating this dataset), others can be used to generate interesting hypotheses regarding links between diseases based on their cytokine association patterns. To validate MeSH descriptor-derived disease-cytokine patterns and to illustrate the usefulness of incorporating cytokine gene expression data into such analyses, cytokine fold changes in gene expression were compared between several diseases. The examples we present herein clearly demonstrate that disease similarities found by examining gene expression and genetic markers can also be captured by MeSH descriptor cooccurrences. By integrating our MeSH descriptor co-occurrence data with gene expression data, we were able to identify cytokine-disease associations that are potentially interesting but have not been extensively investigated in the past. This type of analysis can be used to assist in detecting new, potentially fruitful, and unaddressed areas of research. Furthermore, such analyses can easily be adopted and applied to other biomedical fields (such as cancer) in which gene expression data or other experimental data, such as proteomic or SNP data, is available.
Evaluation and Limitations of Using MeSH Descriptor Co-occurrences
The approach we took to capturing disease-and immune-related associations from MeSH descriptors has some limitations. One of the assumptions of our method is that co-occurrences of MeSH descriptors within a PubMed record represent a true relationship or dependency. In our evaluation of the extent to which MeSH descriptor cooccurrences represent real relationships, we found that over 70% of co-occurrences of different types of entities (disease, cell type, or cytokine) were found to represent true direct or indirect dependencies. Furthermore, because our evaluation approach was based on abstracts rather than the full text of articles, we have likely underestimated the accuracy of our MeSH descriptor-derived data, missing associations captured by MeSH descriptors that are mentioned in the full texts of the articles but not in the abstracts. One possible way to increase the ability of MeSH descriptor co-occurrences to accurately represent real relationships is to limit the selection of PubMed records to those linked to relevant MeSH descriptors that are designated as the major topics of the article. Another possibility is to leverage MeSH qualifiers. MeSH qualifiers are mainly used to group citations that are concerned with a particular aspect of a MeSH descriptor of interest. Qualifiers such as "diagnosis," "immunology," and "blood" can be used to filter MeSH descriptors considered in co-occurrence analyses. However, both of these approaches are likely to greatly reduce the size of the dataset. The ability of our MeSH descriptor-derived data to capture medical knowledge, as demonstrated by our clustering results and by cytokine gene expression patterns, affirms this dataset's quality and its representation of real immune-disease associations and actual medical views.
A second shortcoming of using only MeSH descriptor co-occurrences data is that even if these co-occurrences correctly capture an association between two concepts, the type of association (such as "stimulates," "inhibits," etc.) the direction of the association or the sentiment of the relationship (positive or negative) are not captured. The circles in the intersection of each disease pair illustrate the size and direction of the correlation (the larger the circle is, the stronger the correlation; the closer the color to blue, the more positive the correlation; and the closer the color to pink, the more negative the correlation). Future development of this dataset will include attempts to capture specific semantic relations between cytokines, cells, and diseases and could be aided by the use of natural language processing tools such as SemRep. 10 
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Future Directions
The work presented here, specifically, the analyses of the MeSH descriptor-derived co-occurrences data, indicates that the knowledge extracted from this data is sufficient and accurate enough to reflect current medical knowledge. Future work will include the addition of well-established cytokine-cell and disease-cell associations from several resources (such as medical text-books 42 and canonical pathways [43] [44] [45] [46] [47] ). By incorporating well-established relationships between cytokines, diseases, and cell types, a better model of these relationships can be generated and used to validate the other forms of knowledge (such as that generated from experimental data).
This work also sets out to examine the differences between cytokines and cells as regards their use as diagnostic measures and therapeutic agents (as captured in the biomedical literature). To construct a basis for this, we captured subsets of diseases, cytokines, and cell co-occurrences that were found in PubMed records also linked to diagnostic or therapeutic-related MeSH descriptors (Figure 2) . Future work will focus on utilizing this basis to investigate the differences between cytokine associations of diseases in the context of diagnostics and in the context of therapeutics. The strength of such an analysis will come from the "automated" review and summarization of many publications, which could suggest several factors that could be used, possibly together, as diagnostic markers or as therapeutic agents.
Another key future development will focus on immune-related clinical data. This type of data is starting to become available through various platforms, such as ImmPort 48 and Clinical Study Data Request. 49 However, appropriate methods for these data's capture, representation, and integration need to be identified. Overall, this study has demonstrated that the currently available data has already proved to be very useful for investigating the role that cytokines play in disease.
CONCLUSIONS
Integrating MeSH descriptor-derived association and cytokine gene expression data holds the potential for new discoveries in diseaserelated immunity. Herein, we demonstrated the usefulness of this approach for capturing immune-related patterns, generating feasible hypotheses about disease and immunological mechanisms, and focusing on potentially useful avenues of future research. We have shown that, using integrated large-scale data, such as that presented here, can help achieve a better understanding of the immune mechanisms underlying disease. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
